New Advisory for GSK and Pfizer's RSV Vaccines Due to Rare Neurological Disorder Risks

In a newly released advisory, health authorities have notified clinicians and the public about a potential risk associated with the respiratory syncytial virus (RSV) vaccines developed by GSK and Pfizer. These vaccines, which have been hailed as significant advancements in the fight against RSV, are now under scrutiny due to reports revealing a rare neurological disorder potentially linked to their use.

Continue reading

Japan's Fiscal Strategy: FY25 Debt Servicing Rate Set at 2%

In a significant move reflecting Japan's fiscal policy outlook, the government is poised to establish the initial debt servicing rate for the fiscal year 2025 at a notable 2%. This decision comes at a time when the nation is grappling with various economic challenges, including inflationary pressures, rising interest rates, and the ongoing impact of global economic shifts.

Continue reading